Back

G6PD deficiency sensitizes metastasizing melanoma cells to oxidative stress and glutaminolysis

Aurora, A. B.; Khivansara, V.; Leach, A.; Gill, J. G.; Martin-Sandoval, M.; Yang, C.; Kastininon, S. Y.; Bezwada, D.; Tasdogan, A.; Gu, W.; Mathews, T. P.; Zhao, Z.; DeBerardinis, R. J.; Morrison, S. J.

2021-11-12 cancer biology
10.1101/2021.11.11.468286 bioRxiv
Show abstract

The pentose phosphate pathway is a major source of NADPH for oxidative stress resistance in cancer cells but there is limited insight into its role in metastasis, when some cancer cells experience high levels of oxidative stress. To test this, we mutated the substrate binding site of Glucose-6-phosphate dehydrogenase (G6PD), which catalyzes the first step of the pentose phosphate pathway, in patient-derived melanomas. G6PD mutant melanomas had significantly decreased G6PD enzymatic activity and depletion of intermediates in the oxidative branch of the pentose phosphate pathway. Reduced G6PD function had little effect on the formation of primary subcutaneous tumors but when these tumors spontaneously metastasized the frequency of circulating melanoma cells in the blood and metastatic disease burden were significantly reduced. G6PD mutant melanomas exhibited increased levels of reactive oxygen species (ROS), decreased NADPH levels, and depleted glutathione as compared to control melanomas. G6PD mutant melanomas compensated for this increase in oxidative stress by increasing the production of NADPH through glutaminolysis. This generated a new metabolic vulnerability as G6PD mutant melanomas were more dependent upon glutamine as compared to control melanomas. The oxidative pentose phosphate pathway and compensatory glutaminolysis thus confer layered protection against oxidative stress during metastasis. SignificanceMelanoma metastasis is limited by oxidative stress. Cells that enter the blood experience high levels of ROS and usually die of ferroptosis. We found that melanoma cells become more dependent upon the oxidative branch of the pentose phosphate pathway to manage oxidative stress during metastasis. When pentose phosphate pathway function was disabled by G6PD mutation, the melanoma cells increased their utilization of malic enzyme, fueled by increased consumption of glutamine in the tricarboxylic acid cycle. Melanoma cells thus have redundant and layered protection against oxidative stress.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Cancer Research
130 papers in training set
Top 0.1%
18.8%
2
Science Advances
1243 papers in training set
Top 1%
9.0%
3
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 4%
8.0%
4
eLife
5828 papers in training set
Top 12%
8.0%
5
Nature Communications
5641 papers in training set
Top 22%
7.4%
50% of probability mass above
6
Journal of Clinical Investigation
179 papers in training set
Top 0.5%
6.3%
7
Cancer Research Communications
51 papers in training set
Top 0.3%
3.3%
8
Oncogene
85 papers in training set
Top 0.6%
3.3%
9
JCI Insight
277 papers in training set
Top 2%
3.3%
10
Redox Biology
70 papers in training set
Top 0.4%
2.8%
11
Journal of Biological Chemistry
690 papers in training set
Top 4%
2.7%
12
Cell Reports
1498 papers in training set
Top 15%
2.4%
13
Cancers
213 papers in training set
Top 3%
1.8%
14
Communications Biology
993 papers in training set
Top 20%
1.1%
15
mBio
833 papers in training set
Top 10%
1.1%
16
PNAS Nexus
159 papers in training set
Top 2%
1.1%
17
Molecular Cancer Research
49 papers in training set
Top 1%
0.9%
18
iScience
1154 papers in training set
Top 33%
0.9%
19
Science
477 papers in training set
Top 8%
0.9%
20
Cancer Immunology Research
35 papers in training set
Top 0.9%
0.6%
21
Pigment Cell & Melanoma Research
11 papers in training set
Top 0.3%
0.6%
22
British Journal of Cancer
49 papers in training set
Top 2%
0.6%
23
Frontiers in Oncology
103 papers in training set
Top 4%
0.6%